By clicking a link on this page, you are leaving our website.  Kala Pharmaceuticals assumes no responsibility for information or statements about the Company you may encounter on the internet outside of our website.  Thank you for visiting

April 13, 2016, FierceBiotech
Langer-backed startup Kala Pharma bags $68M round for PhIII drive

April 13, 2016,
Kala Pharmaceuticals to advance eyedrop treatment with $68M

April 13, 2016, Xconomy
Kala Pharma Nabs $68M, Crossover Backers for Eye Drug Push

April 30, 2014, Healio Ophthalmology
Nanotechnology to play large role in future of ophthalmology

April 24, 2014, Healio Ophthalmology
Kala raises $22.5 million to advance clinical trials

April 23, 2014, Xconomy
Kala Pharma Grabs $22.5M More for Eye Drugs

April 23, 2014, FierceBiotech
Kala reels in $22.5M to get its next-gen eyedrops into PhIII

March 17, 2014, Mass High Tech
Mass High Tech Names 2014 Women to Watch

January 2014, Genetic Engineering & Biotechnology News
Setting Sights on Ocular Disorders New Therapeutic Options Are in Development for Age-Related Macular Degeneration

November 2013, Healio
OSN Video Perspective with Guillaume Pfefer

May 2013, Forbes/Wolfe Emerging Tech Report
Start-Up Eyes Big Opportunity In Drug Delivery

May 2013, FierceDrugDelivery
Langer’s Kala touts positive results for topical wet AMD treatment

March 2013, Start-Up Magazine
Kala Pharmaceuticals, Nanoformulations to Treat Eye Disease

March 4, 2013, BioCentury
Easy on the eyes

February 28, 2013, Xconomy
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs

February 28, 2013, FierceBiotech
Langer biotech Kala earmarks $11.5M round for next-gen ophthalmology drug

February 14, 2013, FierceBiotech
Early-stage investor Lux targets biotech with new $245M VC fund

February 12, 2013, Fierce Biotech
Robert Langer, Kala’s co-founder, named One of the 25 Most Influential People in Biopharma Today

February 5, 2013, FierceDrugDelivery
Langer’s Kala scores Cystic Fibrosis Foundation grant

February 1, 2013, The White House
Robert Langer, Kala’s co-founder, Receives National Medal of Technology and Innovation

November 24, 2012, New York Times
Hatching Ideas, and Companies, by the Dozens at M.I.T.

July 13, 2012, Xconomy
Kala, ImmunoGen & More Boston Life Sciences News

July 12, 2012, FierceBiotech
New Kala CEO plans to raise funds for particle tech programs

July 12, 2012, Mass High Tech
Kala Pharmaceuticals taps ex-Sanofi exec as its CEO

July 12, 2012, SciBx
Crossing the mucus barrier

July 12, 2012, SCRIP
Mucus-focused Kala prepares to add to $11m seed funding

July 12, 2012, Pink Sheet
Backed By Key Investors, Kala Pharmaceuticals Taps Its First CEO

March 14, 2012, Xconomy
Kala Pharmaceuticals Lands $6,200,000 Seed Round

March 14, 2012, FierceBiotech
Langer upstart rakes in fresh venture cash for mucus-targeting drugs